Planning for Trial Success
Product development refers to the multifaceted, long-term, highly regulated process that brings promising new drugs, vaccines and medical devices to the populations who most need them. In fields such as HIV vaccine development, where the absence of commercial incentives can make it difficult for companies to lead this process on their own, inventors need to work in partnership with diverse stakeholders and funders to maximize the social and economic impact of their research.
Anne Mullin, PhD, Engagement Leader and Director, Team Performance and Development at Shift Health, outlined the elements of planning for trial success:
- Build contingency plans around potential scenarios
- Define proactive and reactive responses in a prescriptive and unambiguous manner
- Ensure that contingency plans set the stage for future product access.